Skip to content
DataLookout
Menu

NOVEL-2NCT05568966

Collection of Blood Samples for New Diagnostic Devices 2

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 3 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 13 words Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 16063 participants (planned 20000)
    • Primary and study completion dates changed from estimate of Sep 20, 2026 to Sep 17, 2026
    • Study description revised
    • Site details revised at 7 of 7 sites
  2. Notable Phase changed: Not applicable → Not specified
    • Primary and study completion pushed from Aug 20, 2026 to Sep 20, 2026
    v5
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Measurement of blood samples from patients with infection, cardiovascular disease, embolism or renal disease in a reference method and in a novel LumiraDx method.
Timeframe: Up to 5 years
Multiple measurements of blood samples from patients with infection, cardiovascular disease, embolism or renal disease in a novel LumiraDx method.
Timeframe: Up to 5 years

Arms and interventions

Blood Draw

Venous blood draw up to 24mL and/or 6 capillary fingersticks Interventions: Diagnostic Test: Venepuncture Diagnostic Test: Fingerstick

Diagnostic tests: Venous blood draw, Fingerstick

Sites

7 sites in 1 country